New drug aims to stop the dizziness when standing up
Symptom relief
Recruiting now
This study tests a new drug called CST-3056 in 12 adults with neurogenic orthostatic hypotension (a sharp drop in blood pressure when standing) caused by Parkinson's disease or pure autonomic failure. The goal is to see if the drug improves blood pressure and reduces symptoms lik…
Phase: PHASE2 • Sponsor: CuraSen Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 12:05 UTC